Clinical Trials
2 trialsNCT00053781 2023-08-04
Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma
Canadian Cancer Trials Group
Phase 2 Completed
NCT00053794 2023-08-04
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
Canadian Cancer Trials Group
Phase 2 Completed